Motaleb, M. A.
Attalah, K M
Shweeta, H A
Ibrahim, I. T.
Funding for this research was provided by:
Egyptian Atomic Energy Authority
Article History
Received: 26 August 2022
Accepted: 3 March 2023
First Online: 15 March 2023
Declarations
:
: In compliance with the guidelines set out by the Egyptian Atomic Energy Authority, the animal Ethics Committee, Labeled Compounds Department, and the protocol approval of Research Ethics Committee in the Faculty of Pharmacy, Cairo University (REC-FOPCU), Egypt, the biodistribution studies were performed. This study was conducted in accordance with the ARRIVE guidelines (ExternalRef removed).
: Not applicable.
: The authors declare that they have no competing interests.